Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2006
07/26/2006CN1809552A Cannabinoid derivatives, methods of making, and use thereof
07/26/2006CN1809540A Inhibitors of Akt activity
07/26/2006CN1809538A Cis-2,4,5-triaryl-imidazolines
07/26/2006CN1809536A Inhibitors of Akt activity
07/26/2006CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents
07/26/2006CN1809354A Akt活性抑制剂 Akt activity inhibitor
07/26/2006CN1807428A Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses
07/26/2006CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists
07/25/2006US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
07/25/2006US7081454 Anticancer agents
07/25/2006CA2159603C Quinolines as type iv phosphodiesterase inhibitors
07/20/2006WO2006076702A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF
07/20/2006WO2006076619A1 Water-soluble tetrazolium salts
07/20/2006WO2006076529A1 Indole derivatives for treating viral infections
07/20/2006WO2006076509A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
07/20/2006WO2006075619A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
07/20/2006WO2006074884A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists
07/20/2006WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006WO2006037032A3 Prodrugs of protein tyrosine kinase inhibitors
07/20/2006WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
07/20/2006WO2006020277A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
07/20/2006WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
07/20/2006US20060161007 Oxazole and thiazole combinatorial libraries
07/20/2006US20060161005 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection
07/20/2006US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use
07/20/2006US20060160886 Chemical compounds
07/20/2006US20060160885 Chemical compounds
07/20/2006US20060160869 Ubiquitin ligase inhibitors
07/20/2006US20060160857 5-(Pyridin-3-ylamino)-thiazole-4-carboxylic acid (6-methyl-pyridin-2-yl)-amide; metabotropic glutamate receptor antagonists; neurological disorders such as anxiety and chronic or acute pain
07/20/2006US20060160851 Substituted piperidine carbamates
07/20/2006US20060160846 Quinoline derivatives
07/20/2006US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR
07/20/2006US20060160832 Nitrogen-containing aromatic derivatives
07/20/2006US20060160818 Ocular hypotensive agent
07/20/2006US20060160808 New carboxylic acid derivatives, their preparation and their use
07/20/2006US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
07/20/2006US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
07/20/2006US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/20/2006US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
07/20/2006US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis
07/20/2006US20060159882 Optical recording materials having high storage density
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006CA2594813A1 Water-soluble tetrazolium salts
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2593450A1 Indole derivatives for treating viral infections
07/20/2006CA2593439A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists
07/20/2006CA2592611A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
07/19/2006EP1681287A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1681286A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1680431A1 Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
07/19/2006EP1680418A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
07/19/2006EP1680417A1 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
07/19/2006EP1680406A1 N-substituted benzene sulfonamides
07/19/2006EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
07/19/2006EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/19/2006EP1370556B1 Metalloproteinase inhibitors
07/19/2006EP1299361B1 Pyrazole derivatives
07/19/2006EP1194146B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
07/19/2006CN1805957A Azetidine compounds
07/19/2006CN1805951A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
07/19/2006CN1805945A Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1805929A Phosphodiesterase 4 inhibitors
07/19/2006CN1805923A Benzamide derivative or salt thereof
07/19/2006CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors
07/19/2006CN1803798A Method for producing fungicide compand
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists
07/19/2006CN1264839C Non-nucleoside reverse transcriptase inhibitors
07/19/2006CN1264838C Indole derivatives for treating central nervous system disease
07/19/2006CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II
07/19/2006CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
07/18/2006USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078536 Antiproliferative agents; for prevention of infections; for veterinary medicine, agriculture
07/18/2006US7078529 Imidazole derivatives
07/18/2006US7078424 Central nervous system disorders; alopecia
07/18/2006US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders
07/18/2006US7078422 Activator for peroxisome proliferator-activated receptor
07/18/2006US7078419 Cytokine inhibitors
07/18/2006US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
07/18/2006US7078406 using derivatives of 2-(4'-sulfamoylphenyl)-5-(4'-dimethylaminophenyl)oxazoles to monitor a cell environment; improved utility in thermal shift bioassays
07/18/2006US7078403 Antiviral agents
07/18/2006CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators
07/18/2006CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them
07/18/2006CA2242425C Quinazoline derivatives as vegf inhibitors
07/13/2006WO2006074388A2 TRICYCLIC δ-OPIOID MODULATORS
07/13/2006WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
07/13/2006WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
07/13/2006WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073363A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006WO2006072436A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006WO2006072351A1 Heteroaryl-substituited pyrazolines as par-1 antagonists
07/13/2006WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors